People · Operator
Named in public records as an officer, director or promoter · active 2015–2021 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Relievant MedSystems Inc | — | Other Health Care | Series C | $200.1M | $523.3M | 2015 |
| Sollis Therapeutics Inc | — | Biotechnology | Seed | $5.0M | $78.5M | 2020 |
Alex DiNello at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Alex DiNello on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Ryan | 1 | 17 |
| Ross Jaffe | 1 | 7 |
| Brent Ahrens | 1 | 7 |
| Justin Klein | 1 | 6 |
| Peter Klein | 1 | 5 |
| David Amerson | 1 | 5 |
| Kevin Hykes | 1 | 4 |
| ARTHUR TAYLOR | 1 | 4 |
| Richard Mott | 1 | 3 |
| Art Taylor | 1 | 3 |
| Alexander Schmitz | 1 | 2 |
| Jason Lettman | 1 | 2 |
| Chris Geyen | 1 | 2 |
| Jason Lettmann | 1 | 2 |
| Cynthia Lucchese | 1 | 1 |
| Tyler Binney | 1 | 1 |
| Ray Baker | 1 | 1 |
| Ray Baker, MD | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.